sr 95531 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Trials (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) |
---|---|---|---|---|---|
610 | 0 | 209 | 793 | 0 | 110 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cox, CL; Yang, S | 1 |
1 other study(ies) available for sr 95531 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
Article | Year |
---|---|
Modulation of inhibitory activity by nitric oxide in the thalamus.
Topics: Action Potentials; Anesthetics, Local; Animals; Animals, Newborn; Arginine; Drug Interactions; Enzyme Inhibitors; GABA Antagonists; Geniculate Bodies; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neural Inhibition; Neurons; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Patch-Clamp Techniques; Penicillamine; Pyridazines; Quinoxalines; Rats; Tetrodotoxin | 2007 |